Literature DB >> 30906715

A Novel Grading System for Salpingopharyngeal Fold Hypertrophy in Obstructive Sleep Apnoea.

Vikas K Agrawal1, Swati Kodur1, Raghav Hira Jha1.   

Abstract

The present study aimed at reporting the incidence of Salpingopharyngeal Fold (SPF) hypertrophy on Drug Induced Sleep Endoscopy (DISE) in patients with Obstructive Sleep Apnoea (OSA, validate a grading system and analyse the impact of various grades on the clinical presentation while ascertaining its relation with Apnoea-Hypopnoea Index (AHI). A retrospective analysis of 169 patients with polysomnographic confirmation of obstructive sleep apnoea has been done in the study. The DISE video data of 169 patients was evaluated by two ENT surgeons individually and they graded the hypertrophy of the fold as Grade 0 being normal anatomy, Grade 1 being hypertrophy causing partial obstruction and Grade 2 being hypertrophy causing complete obstruction of lateral pharyngeal wall. It was found that the presence of SPF hypertrophy independently adds considerably to the severity of the obstruction, attributing to lateral collapse at the upper retropalatal level and also significantly increases AHI. It is thus advised to consider the grade of SPF hypertrophy while surgically planning the management of patients with OSA.

Entities:  

Keywords:  Agrawal’s grading; Obstructive sleep apnoea; SPF hypertrophy

Year:  2018        PMID: 30906715      PMCID: PMC6401366          DOI: 10.1007/s12070-018-1513-2

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  25 in total

1.  Anatomy of the normal velopharyngeal mechanism.

Authors:  D R Dickson
Journal:  Clin Plast Surg       Date:  1975-04       Impact factor: 2.017

2.  A correlated study of the anatomy and motor activity of the upper pharynx by cadaver dissection and by cinematic study of patients after maxillo-facial surgery.

Authors:  J F BOSMA
Journal:  Ann Otol Rhinol Laryngol       Date:  1953-03       Impact factor: 1.547

3.  Validation of the bispectral index monitor for measuring the depth of sedation in children.

Authors:  Senthilkumar Sadhasivam; Arjunan Ganesh; Amy Robison; Robin Kaye; Mehernoor F Watcha
Journal:  Anesth Analg       Date:  2006-02       Impact factor: 5.108

4.  The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study.

Authors:  C M Baldwin; K A Griffith; F J Nieto; G T O'Connor; J A Walsleben; S Redline
Journal:  Sleep       Date:  2001-02-01       Impact factor: 5.849

Review 5.  Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis.

Authors:  Yoon K Loke; J William L Brown; Chun Shing Kwok; Alagaratnam Niruban; Phyo K Myint
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-07-24

6.  Snoring as a risk factor for type II diabetes mellitus: a prospective study.

Authors:  Wael K Al-Delaimy; JoAnn E Manson; Walter C Willett; Meir J Stampfer; Frank B Hu
Journal:  Am J Epidemiol       Date:  2002-03-01       Impact factor: 4.897

Review 7.  Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis.

Authors:  Sean M Caples; James A Rowley; Jeffrey R Prinsell; John F Pallanch; Mohamed B Elamin; Sheri G Katz; John D Harwick
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

8.  Site of airway obstruction in patients with obstructive sleep apnea before and after uvulopalatopharyngoplasty.

Authors:  A Metes; V Hoffstein; S Mateika; P Cole; J S Haight
Journal:  Laryngoscope       Date:  1991-10       Impact factor: 3.325

9.  Test-retest reliability of drug-induced sleep endoscopy.

Authors:  Krista Rodriguez-Bruno; Andrew N Goldberg; Charles E McCulloch; Eric J Kezirian
Journal:  Otolaryngol Head Neck Surg       Date:  2009-05       Impact factor: 3.497

10.  Uvulopalatopharyngoplasty in the management of obstructive sleep apnea: the mayo clinic experience.

Authors:  Akram Khan; Kannan Ramar; Supriya Maddirala; Oren Friedman; John F Pallanch; Eric J Olson
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.